Catalog/Metabolic

Metabolic

Reta

GLP-3

A long-acting GLP-3 used to study energy-balance and glycemic pathways.

Sequence

  • Hydrophobic
  • Polar
  • Charged

GLP-3 with fatty-acid acylation

YXQGTFTSDYSIXLDKKAQXAFIEYLLEGGPSSGAPPPS
CAS
2381089-83-2
Formula
C223H343F3N46O70
Mass (g/mol)
4731.33
Half-life
~6 days
Form
Lyophilized
Purity
≥98% HPLC

Mechanism

Reta is a GLP-3. It co-activates GIP, GLP-1, and glucagon receptors. The third (glucagon) arm is the research differentiator versus dual agonists such as tirzepatide.

Research notes

Clinical-grade products exist under other labels. Research-grade powder is not those medicines.

Lyophilized: −20 °C, dark. Large acylated peptides adsorb to plastic.

Typical reconstitution

Catalog convenience numbers — not a protocol. Vial 10 mg in 2 mL; default draw 1000 mcg.

Adjacent